Metformin ameliorates the severity of experimental Alport syndrome

Metformin is widely used for the treatment of type 2 diabetes, and increasing numbers of studies have shown that metformin also ameliorates tumor progression, inflammatory disease, and fibrosis. However, the ability of metformin to improve non-diabetic glomerular disease and chronic kidney disease (...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Omachi, Kohei, Kaseda, Shota, Yokota, Tsubasa, Kamura, Misato, Teramoto, Keisuke, Kuwazuru, Jun, Kojima, Haruka, Nohara, Hirofumi, Koyama, Kosuke, Ohtsuki, Sumio, Misumi, Shogo, Takeo, Toru, Nakagata, Naomi, Li, Jian-Dong, Shuto, Tsuyoshi, Suico, Mary Ann, Miner, Jeffrey H., Kai, Hirofumi
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007696/
https://ncbi.nlm.nih.gov/pubmed/33782421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86109-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky